Systematic development of a bioanalytical UPLC-MS/MS method for estimation of risperidone and its active metabolite in long-acting microsphere formulation in rat plasma-Reference-Cited by-同舟云学术

Systematic development of a bioanalytical UPLC-MS/MS method for estimation of risperidone and its active metabolite in long-acting microsphere formulation in rat plasma

Published:2020-12 Issue: Volume:1160 Page:122433
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Rub Rehan Abdur,Beg Sarwar,Kazmi Imran,Afzal Obaid^ORCID,Almalki Waleed H.,Alghamdi Saad,Akhter Sohail,Ali Asgar,Ahmed Farhan J.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference22 articles.

1. Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder;Vermeulen;J. Pharmacokinet. Pharmacodyn.,2007

2. Biochemical profile of risperidone, a new antipsychotic;Leysen;J. Pharmacol. Exp. Ther.,1988

3. The pharmacokinetics of risperidone in humans: a summary;Heykants;J. Clin. Psychiatry.,1994

4. Absorption, metabolism, and excretion of risperidone in humans;Mannens;Drug Metab. Dispos.,1993

5. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects;Huang;J Clin. Pharmacol. Ther.,1993

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the greenness to determine risperidone in commercial products using a green stability-indicating HPTLC method;Arabian Journal of Chemistry;2024-04

2. Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia;International Clinical Psychopharmacology;2023-11-02

3. Development and Validation of a Novel UHPLC-MS/MS Method for the Quantification of Plinabulin in Plasma and Its Application in a Pharmacokinetic Study with Leukopenic Rats;Pharmaceuticals;2023-08-14

4. Application of the “Method Operable Design Region” (MODR) approach for the development of a UHPLC method for the assay and purity determination of risperidone in risperidone drug substance and other formulations;Biomedical Chromatography;2022-07-18

5. Analytical Method Development for 19 Alkyl Halides as Potential Genotoxic Impurities by Analytical Quality by Design;Molecules;2022-07-11